|
Yale Comprehensive Cancer Center Support Grant
|
2P30CA016359-34
|
$2,531,005
|
LYNCH, THOMAS
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-34S1
|
$75,000
|
Lynch, Thomas
|
YALE UNIVERSITY
|
|
Vitamin D Analogs as Adjuvants in Chemotherapy of Cancer
|
6R01CA044722-23
|
$191,385
|
Studzinski, George
|
RBHS-NEW JERSEY MEDICAL SCHOOL
|
|
Validation of microRNAs as therapeutic targets in hematological malignancies
|
5R01CA135332-03
|
$297,452
|
MARCUCCI, GUIDO
|
OHIO STATE UNIVERSITY
|
|
Validating a novel biomarker of clinical progression and survival in CLL
|
5R33CA161731-03
|
$364,740
|
DAVIS, RANDALL
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
UW Comprehensive Cancer Center Support
|
2P30CA014520-39
|
$4,133,528
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-39S1
|
$37,429
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-39S2
|
$122,414
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
University of Kentucky Markey Cancer Center - Cancer Center Support Grant
|
1P30CA177558-01
|
$1,402,503
|
EVERS, BERNARD
|
UNIVERSITY OF KENTUCKY
|
|
University of Kentucky Markey Cancer Center - Cancer Center Support Grant
|
3P30CA177558-01S1
|
$75,000
|
EVERS, BERNARD
|
UNIVERSITY OF KENTUCKY
|
|
University of Hawaii Cancer Center CCSG
|
3P30CA071789-14S1
|
$113,245
|
CARBONE, MICHELE
|
UNIVERSITY OF HAWAII AT MANOA
|
|
University of Hawaii Cancer Center CCSG
|
3P30CA071789-14S2
|
$71,639
|
CARBONE, MICHELE
|
UNIVERSITY OF HAWAII AT MANOA
|
|
University of Hawaii Cancer Center CCSG
|
5P30CA071789-14
|
$1,063,659
|
CARBONE, MICHELE
|
UNIVERSITY OF HAWAII AT MANOA
|
|
Understanding Hemotopoietic Neoplasias using Humanized Mice
|
5R01CA156689-04
|
$461,009
|
Flavell, Richard
|
YALE UNIVERSITY
|
|
Translational Research in Cancer
|
2P30CA056036-14
|
$2,647,679
|
PESTELL, RICHARD
|
THOMAS JEFFERSON UNIVERSITY
|
|
Translational Research in Cancer
|
3P30CA056036-14S1
|
$73,216
|
PESTELL, RICHARD
|
THOMAS JEFFERSON UNIVERSITY
|
|
Translational Investigation of KRas & NF1 in Myeloid Leukemia
|
5R37CA072614-17
|
$286,486
|
SHANNON, KEVIN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
TOWARD AN UNDERSTANDING OF CLL PROGRESSION
|
5R01CA151319-03
|
$352,327
|
CROCE, CARLO
|
OHIO STATE UNIVERSITY
|
|
Therapeutic Targeting of Leukemia-Microenvironmental Interactions
|
1R01CA166280-01A1
|
$318,513
|
CALVI, LAURA
|
UNIVERSITY OF ROCHESTER
|
|
The UT MD Anderson Cancer Center Community Clinical Oncology Program Research Bas
|
5U10CA045809-25
|
$1,885,277
|
FISCH, MICHAEL
|
UT MD ANDERSON CANCER CTR
|
|
The Therapy of CML
|
5P01CA049639-23
|
$3,383,296
|
CHAMPLIN, RICHARD
|
UT MD ANDERSON CANCER CTR
|
|
The Role of the APC Tumor Suppressor Gene in Hematopoiesis and Leukemogenesis
|
5R01CA140979-04
|
$306,229
|
QIAN, ZHIJIAN
|
UNIVERSITY OF ILLINOIS
|
|
The Role of Telomere Shortening in MDS-AML Pathogenesis (resubmission)
|
5R01CA160433-02
|
$315,981
|
ARMANIOS, MARY
|
JOHNS HOPKINS UNIVERSITY
|
|
The role of ICSBP in the pathogenesis of chronic myeloid leukemia
|
1R01CA174205-01
|
$320,588
|
Eklund, Elizabeth
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
2P30CA060553-19
|
$4,635,678
|
ROSEN, STEVEN
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-19S1
|
$75,000
|
Rosen, Steven
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-19S2
|
$50,000
|
Rosen, Steven
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Impact of Hspa9 Haploinsufficiency on Murine Hematopoiesis and Leukemogenesis
|
5F31CA165702-02
|
$28,498
|
Krysiak, Kilannin
|
WASHINGTON UNIVERSITY
|
|
Targeting the C/EBPalpha-Gfi-pathway in CML stem cells
|
1R01CA167169-01A1
|
$321,625
|
CALABRETTA, BRUNO
|
THOMAS JEFFERSON UNIVERSITY
|
|
Targeting PML for therapy in leukemia-initiating cells
|
5R00CA139009-04
|
$234,060
|
Ito, Keisuke
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Targeting PML for leukemia therapy.
|
5R01CA142874-04
|
$425,460
|
PANDOLFI, PIER PAOLO
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Targeting BCL6 in tyrosine kinase-driven leukemia
|
1R01CA169458-01A1
|
$325,602
|
Muschen, Markus
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Targeted Improvement in Stem Cell Therapy for Leukemia and Bone Marrow Failure Sy
|
5R01CA157537-03
|
$298,427
|
PANG, QISHEN
|
CINCINNATI CHILDRENS HOSP MED CTR
|
|
T cell repertoire of graft-versus-host disease and graft-versus-tumor effects
|
5R01CA154244-09
|
$365,317
|
Korngold, Robert
|
HACKENSACK UNIVERSITY MEDICAL CENTER
|
|
Systems Biology of Diversity in Cancer
|
5U54CA148967-04
|
$2,702,738
|
SANDER, CHRIS
|
SLOAN-KETTERING INST CAN RES
|
|
Suppression of BCR-ABL by siRNA-loaded Nanoparticles for the Treatment of CML
|
1F31CA174298-01A1
|
$42,232
|
Gavrilov, Kseniya
|
YALE UNIVERSITY
|
|
SunCoast CCOP Research Base at the University of South Florida
|
5U10CA081920-12
|
$2,305,668
|
KRISCHER, JEFFREY
|
UNIVERSITY OF SOUTH FLORIDA
|
|
Study of the Roles of SDF1 and CXCR4 in Hematopoiesis
|
ZIA BC 010782
|
$317,388
|
Tosato, Giovanna
|
CCR (NCI)
|
|
Studies of BCR-ABL leukemogenesis in mice
|
5R01CA090576-13
|
$265,603
|
Van Etten, Richard
|
TUFTS MEDICAL CENTER
|
|
Stanford University Cancer Center
|
3P30CA124435-07S1
|
$75,000
|
MITCHELL, BEVERLY
|
STANFORD UNIVERSITY
|
|
Stanford University Cancer Center
|
5P30CA124435-07
|
$2,890,663
|
MITCHELL, BEVERLY
|
STANFORD UNIVERSITY
|
|
SPORE University of Texas M.D. Anderson Cancer Center SPORE-Leukemia
|
2P50CA100632-11
|
$2,150,500
|
KANTARJIAN, HAGOP
|
UT MD ANDERSON CANCER CTR
|
|
Specialized Cancer Center Support Grant
|
3P30CA023100-27S9
|
$3,858,688
|
LIPPMAN, SCOTT
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Single-Cell Methods for Analysis of Clonal Heterogeneity and Evolution in Cancer
|
1R01CA175215-01
|
$646,486
|
Radich, Jerald
|
FRED HUTCHINSON CAN RES CTR
|
|
Single Molecule Fiber Arrays for the Detection of Low Abundance Proteins
|
6R44CA133987-05
|
$713,497
|
Duffy, David
|
QUANTERIX CORPORATION
|
|
Signal Transduction of Type 1 Interferons in Malignant Cells
|
2R01CA077816-15A1
|
$298,913
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Sapacitabine therapy to create synthetic lethality in DNA repair-deficient CLL
|
5R01CA163802-02
|
$308,179
|
WIERDA, WILLIAM
|
UT MD ANDERSON CANCER CTR
|
|
Roswell Park Cancer Institute Center Support Grant
|
3P30CA016056-36S4
|
$3,763,390
|
TRUMP, DONALD
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Roswell Park Cancer Institute Center Support Grant
|
3P30CA016056-36S5
|
$43,749
|
TRUMP, DONALD
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Roswell Park Cancer Institute Center Support Grant
|
3P30CA016056-36S6
|
$33,330
|
TRUMP, DONALD
|
ROSWELL PARK CANCER INSTITUTE CORP
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|